Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy
Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no...
Saved in:
Published in | Molecular therapy Vol. 23; no. 7; pp. 1248 - 1261 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.07.2015
Elsevier Limited Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFNγ between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFNγ prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFNγ stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFNγ responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFNγ responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals. |
---|---|
AbstractList | Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFNγ between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFNγ prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFNγ stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFNγ responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFNγ responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals. Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFNγ between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFNγ prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFNγ stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFNγ responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFNγ responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals. Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFN[gamma] between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFN[gamma] prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFN[gamma] stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFN[gamma] responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFN[gamma] responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals. |
Author | Arafat, Dalia Kugathasan, Subra Garcia, Marco Gibson, Greg Copland, Ian B Galipeau, Jacques Ng, Spencer Prasad, Mahadev Chinnadurai, Raghavan |
Author_xml | – sequence: 1 givenname: Raghavan surname: Chinnadurai fullname: Chinnadurai, Raghavan organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA – sequence: 2 givenname: Ian B surname: Copland fullname: Copland, Ian B organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA – sequence: 3 givenname: Spencer surname: Ng fullname: Ng, Spencer organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA – sequence: 4 givenname: Marco surname: Garcia fullname: Garcia, Marco organization: Emory Healthcare, Atlanta, Georgia, USA – sequence: 5 givenname: Mahadev surname: Prasad fullname: Prasad, Mahadev organization: Department of Pediatrics, Emory University, Atlanta, Georgia, USA – sequence: 6 givenname: Dalia surname: Arafat fullname: Arafat, Dalia organization: School of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA – sequence: 7 givenname: Greg surname: Gibson fullname: Gibson, Greg organization: School of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA – sequence: 8 givenname: Subra surname: Kugathasan fullname: Kugathasan, Subra organization: Department of Pediatrics, Emory University, Atlanta, Georgia, USA – sequence: 9 givenname: Jacques surname: Galipeau fullname: Galipeau, Jacques email: jgalipe@emory.edu organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25899824$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUttq3DAQNSWlubQv_YBi6ENLibeWrYv1Ugjbpl1IaSF5F1p5vKtgS44kh-5f9JM7ZpPQhkARjAbNOYfRnDnODpx3kGWvSbkgZd18HNKiKglbcPEsOyKsYkVZVvTgISf8MDuO8RozwiR_kR1WrJGyqehR9vs7RHBmuxt0n1-m4Od7CX0f888Q7C20-Tk-5svgt-5dzH_qZMGluTr2fpevXOt70IN1kFenddFa_2u3AacjFAO0VidUWA3DhPXLaRwDxGi9O52JMAIGl3Lf5WdT8uNWb3Yvs-ed7iO8urtPsqvzL1fLb8XFj6-r5dlFYSiXoiBdozldG4xMsnVVU9Ea2nLeEcak7kgJomtbqRnXeBoBumo0ZbI1ghBTn2Sf9rLjtMY-DbYRdK_GYAcddsprq_6tOLtVG3-raEOEkAwF3t8JBH8zQUxqsNHg4LQDP0WFKM4ZJaX8P5TLSrBaVrPq20fQaz8Fh4NAQUnqmgnaIOrN380_dH1vKwLKPcAEH2OAThmb0Dk__8X2ipRq3hw1JDVvjuICKR8eUe5VnwTTPRjQoVsLQUWDa2HQ8AAmqdbbp2h_AGQ316s |
CitedBy_id | crossref_primary_10_1021_acs_chemrestox_4c00114 crossref_primary_10_1016_j_celrep_2018_02_013 crossref_primary_10_1093_stcltm_szac050 crossref_primary_10_3390_cells9020431 crossref_primary_10_1016_j_ymthe_2025_02_003 crossref_primary_10_3389_fcell_2020_00447 crossref_primary_10_1093_ibd_izy130 crossref_primary_10_1093_stcltm_szac054 crossref_primary_10_1182_bloodadvances_2017006205 crossref_primary_10_3389_fimmu_2020_00422 crossref_primary_10_1016_j_jcyt_2015_11_008 crossref_primary_10_1093_stcltm_szad003 crossref_primary_10_1111_cei_12929 crossref_primary_10_1158_1541_7786_MCR_19_0509 crossref_primary_10_1186_s13287_020_02121_8 crossref_primary_10_1155_2015_746392 crossref_primary_10_4252_wjsc_v12_i7_688 crossref_primary_10_32604_biocell_2023_042586 crossref_primary_10_3389_fimmu_2019_01228 crossref_primary_10_3389_fcell_2021_715905 crossref_primary_10_1038_s41551_018_0325_8 crossref_primary_10_1089_bioe_2020_0006 crossref_primary_10_1016_j_ejphar_2024_176719 crossref_primary_10_3390_cells11091376 crossref_primary_10_1016_j_bbrc_2024_149591 crossref_primary_10_1038_emm_2017_104 crossref_primary_10_1002_stem_2415 crossref_primary_10_3389_fonc_2020_01632 crossref_primary_10_3389_fphar_2018_00179 crossref_primary_10_3389_fcell_2020_596079 crossref_primary_10_1002_ueg2_12477 crossref_primary_10_1111_apt_13717 crossref_primary_10_1186_s13287_018_0981_3 crossref_primary_10_1186_s40364_019_0156_0 crossref_primary_10_1016_j_jtct_2021_02_002 crossref_primary_10_3390_cells11091503 crossref_primary_10_1093_stmcls_sxae040 crossref_primary_10_3389_fimmu_2022_943333 crossref_primary_10_1016_j_bbmt_2017_01_081 crossref_primary_10_1016_j_autrev_2019_02_004 crossref_primary_10_1016_j_jcyt_2020_09_008 crossref_primary_10_1080_15548627_2019_1630223 crossref_primary_10_1007_s12026_016_8798_6 crossref_primary_10_1016_j_radonc_2024_110093 crossref_primary_10_1186_s13287_021_02645_7 crossref_primary_10_3390_cells8070764 |
Cites_doi | 10.3389/fgene.2012.00243 10.3109/14653240903121260 10.1182/blood-2013-03-491555 10.1016/j.cgh.2013.06.021 10.1002/jcp.24081 10.1073/pnas.1407001111 10.1074/jbc.M109.037671 10.1038/nrgastro.2013.66 10.1007/s00109-012-0934-8 10.1016/j.autrev.2013.10.007 10.1016/j.molmed.2009.03.002 10.1016/j.jcyt.2012.10.002 10.1038/emm.2013.94 10.1038/nature07383 10.1038/mt.2011.189 10.1002/stem.1729 10.1074/jbc.M800266200 10.1007/s12016-012-8347-6 10.3109/14653249.2010.548379 10.1038/nri3209 10.1182/blood-2008-07-166892 10.1080/14653240600855905 10.1182/blood.V99.5.1610 10.1016/j.jcyt.2013.02.010 10.1016/j.stem.2007.11.014 10.1155/2013/929842 10.2174/13894501113146660234 10.1146/annurev.physiol.70.113006.100646 10.1038/nature13044 10.1016/j.ajhg.2011.11.029 10.1016/j.stem.2013.09.006 10.1136/ard.2007.071233 10.4049/jimmunol.179.3.1549 10.1038/ng2032 10.1136/gut.2010.215152 10.1136/gut.2010.228908 10.4049/jimmunol.1301828 10.1016/j.stemcr.2014.05.003 10.1155/2012/826182 10.1093/rheumatology/kel267 10.1038/nature07416 10.1038/mt.2008.296 10.1084/jem.20070906 10.3109/14653249.2011.623691 10.1080/14653240500319234 10.1016/j.humimm.2012.11.008 10.1016/j.biomaterials.2013.06.050 10.1002/ibd.21312 10.1182/blood-2005-03-1004 10.1038/ng1954 |
ContentType | Journal Article |
Copyright | 2015 American Society of Gene & Cell Therapy Copyright Nature Publishing Group Jul 2015 Copyright © 2015 American Society of Gene & Cell Therapy 2015 American Society of Gene & Cell Therapy |
Copyright_xml | – notice: 2015 American Society of Gene & Cell Therapy – notice: Copyright Nature Publishing Group Jul 2015 – notice: Copyright © 2015 American Society of Gene & Cell Therapy 2015 American Society of Gene & Cell Therapy |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7QO 7T5 8FD FR3 H94 P64 5PM |
DOI | 10.1038/mt.2015.67 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database ProQuest Biological Science ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Biotechnology Research Abstracts Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE ProQuest Central Student AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1525-0024 |
EndPage | 1261 |
ExternalDocumentID | PMC4817795 4067862091 25899824 10_1038_mt_2015_67 S1525001616301551 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Atlanta Georgia United States--US Georgia |
GeographicLocations_xml | – name: Atlanta Georgia – name: United States--US – name: Georgia |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: T32 GM008169 |
GroupedDBID | --- --K 0R~ 123 1B1 29M 2WC 36B 39C 3V. 4.4 53G 6I. 7X7 88E 8FE 8FH 8FI 8FJ AACTN AAEDW AAFTH AAIAV AALRI AAVLU AAXUO ABAWZ ABJNI ABMAC ABUDA ABUWG ABVKL ACGFO ACGFS ACPRK ADBBV ADFRT ADJPV ADMUD ADQMX AEDAW AENEX AFKRA AFTJW AGAYW AHMBA AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS ASPBG AVWKF AZFZN BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 DIK DU5 E3Z EBS EJD EMB EMOBN F5P FDB FEDTE FRP FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IHE JIG JSO KQ8 LG5 LK8 M1P M41 M7P NCXOZ NQ- O9- OK1 P2P PQQKQ PROAC PSQYO RCE RIG RNS RNTTT ROL RPM RPZ SEW SSZ SV3 TR2 UHS UKHRP W2D XPP ZA5 ZMT AAMRU AAYWO AAYXX ABDGV ABWVN ACRPL ACVFH ADCNI ADNMO ADVLN AEUPX AFPUW AGCQF AIGII AKAPO AKBMS AKRWK AKYEP ALIPV APXCP CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC DWQXO EFKBS GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 PUEGO 7QO 7T5 8FD FR3 H94 P64 5PM |
ID | FETCH-LOGICAL-c4697-1f8a64bc8a6595b2347dc4d66f1559af10e7fdd9a56a6a687ea28a459dc711c3 |
IEDL.DBID | 7X7 |
ISSN | 1525-0016 |
IngestDate | Thu Aug 21 14:12:04 EDT 2025 Thu Jul 10 22:40:40 EDT 2025 Sun Aug 24 03:45:57 EDT 2025 Fri Jul 25 11:08:18 EDT 2025 Wed Feb 19 02:40:04 EST 2025 Tue Jul 01 01:46:45 EDT 2025 Thu Apr 24 22:50:20 EDT 2025 Fri Feb 23 02:31:03 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4697-1f8a64bc8a6595b2347dc4d66f1559af10e7fdd9a56a6a687ea28a459dc711c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1038/mt.2015.67 |
PMID | 25899824 |
PQID | 1791335748 |
PQPubID | 2042164 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4817795 proquest_miscellaneous_1776654109 proquest_miscellaneous_1692753925 proquest_journals_1791335748 pubmed_primary_25899824 crossref_citationtrail_10_1038_mt_2015_67 crossref_primary_10_1038_mt_2015_67 elsevier_sciencedirect_doi_10_1038_mt_2015_67 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-07-01 |
PublicationDateYYYYMMDD | 2015-07-01 |
PublicationDate_xml | – month: 07 year: 2015 text: 2015-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Milwaukee |
PublicationTitle | Molecular therapy |
PublicationTitleAlternate | Mol Ther |
PublicationYear | 2015 |
Publisher | Elsevier Inc Elsevier Limited Nature Publishing Group |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited – name: Nature Publishing Group |
References | Chinnadurai, Waller, Galipeau, Nooka (bib44) 2013; 2013 Rioux, Xavier, Taylor, Silverberg, Goyette, Huett (bib22) 2007; 39 Galipeau (bib12) 2013; 15 Ma, Ning, Xu, Hou, Wang, Hou (bib14) 2013; 122 Tardito, Negrini, Conteduca, Ferrera, Parodi, Battaglia (bib20) 2013; 74 Bocelli-Tyndall, Bracci, Spagnoli, Braccini, Bouchenaki, Ceredig (bib17) 2007; 46 Horwitz, Le Blanc, Dominici, Mueller, Slaper-Cortenbach, Marini, International Society for Cellular Therapy (bib35) 2005; 7 Lassen, Kuballa, Conway, Patel, Becker, Peloquin (bib48) 2014; 111 Armaka, Apostolaki, Jacques, Kontoyiannis, Elewaut, Kollias (bib33) 2008; 205 Fujita, Saitoh, Kageyama, Akira, Noda, Yoshimori (bib49) 2009; 284 Schroepf, Kappler, Brand, Prell, Lohse, Glas (bib43) 2010; 16 Visscher, Brown, McCarthy, Yang (bib19) 2012; 90 Plantinga, Crisan, Oosting, van de Veerdonk, de Jong, Philpott (bib26) 2011; 60 Murthy, Li, Peng, Reichelt, Katakam, Noubade (bib47) 2014; 506 Nath, Arafat, Gibson (bib29) 2012; 3 Hampe, Franke, Rosenstiel, Till, Teuber, Huse (bib21) 2007; 39 Chinnadurai, Copland, Patel, Galipeau (bib28) 2014; 192 Murphy, Moncivais, Caplan (bib3) 2013; 45 Ren, Jin, Sabatino, Balakumaran, Feng, Kuznetsov (bib40) 2011; 13 Gianchecchi, Delfino, Fierabracci (bib24) 2014; 13 Rafei, Hsieh, Fortier, Li, Yuan, Birman (bib41) 2008; 112 François, Galipeau (bib10) 2012; 227 Chinnadurai, Garcia, Sakurai, Lam, Kirk, Galipeau (bib50) 2014; 3 François, Copland, Yuan, Romieu-Mourez, Waller, Galipeau (bib51) 2012; 14 Le Blanc, Mougiakakos (bib1) 2012; 12 François, Romieu-Mourez, Li, Galipeau (bib37) 2012; 20 Tang, Ma, Zhang, Gu, Hou, Gilkeson (bib15) 2012; 2012 Nys, Agostinis, Vermeire (bib25) 2013; 10 Moll, Alm, Davies, von Bahr, Heldring, Stenbeck-Funke (bib9) 2014; 32 Dominici, Le Blanc, Mueller, Slaper-Cortenbach, Marini, Krause (bib34) 2006; 8 Larghero, Farge, Braccini, Lecourt, Scherberich, Foïs (bib16) 2008; 67 Krampera, Galipeau, Shi, Tarte, Sensebe, MSC Committee of the International Society for Cellular Therapy (ISCT) (bib30) 2013; 15 Cadwell, Liu, Brown, Miyoshi, Loh, Lennerz (bib46) 2008; 456 Eliopoulos, Stagg, Lejeune, Pommey, Galipeau (bib8) 2005; 106 Romieu-Mourez, Coutu, Galipeau (bib39) 2012; 4 Saitoh, Fujita, Jang, Uematsu, Yang, Satoh (bib45) 2008; 456 Ren, Zhang, Zhao, Xu, Zhang, Roberts (bib31) 2008; 2 Rameshwar (bib11) 2009; 17 Powell, Pinchuk, Saada, Chen, Mifflin (bib32) 2011; 73 Voswinkel, Francois, Simon, Benderitter, Gorin, Mohty (bib7) 2013; 45 Lapaquette, Brest, Hofman, Darfeuille-Michaud (bib23) 2012; 90 Bernardo, Fibbe (bib2) 2013; 13 Papadaki, Kritikos, Gemetzi, Koutala, Marsh, Boumpas (bib13) 2002; 99 Romieu-Mourez, François, Boivin, Stagg, Galipeau (bib36) 2007; 179 Ricart, Jauregui-Amezaga, Ordás, Pinó, Ramírez, Panés (bib6) 2013; 14 Bernardo, Avanzini, Ciccocioppo, Perotti, Cometa, Moretta (bib18) 2009; 11 Copland, Garcia, Waller, Roback, Galipeau (bib27) 2013; 34 Forbes, Sturm, Leong, Sparrow, Segarajasingam, Cummins (bib5) 2014; 12 Duijvestein, Vos, Roelofs, Wildenberg, Wendrich, Verspaget (bib4) 2010; 59 Zenewicz, Antov, Flavell (bib38) 2009; 15 Cox, Dean, Roberts, Overall (bib42) 2008; 283 Ricart (10.1038/mt.2015.67_bib6) 2013; 14 Larghero (10.1038/mt.2015.67_bib16) 2008; 67 Bernardo (10.1038/mt.2015.67_bib18) 2009; 11 Dominici (10.1038/mt.2015.67_bib34) 2006; 8 François (10.1038/mt.2015.67_bib37) 2012; 20 Visscher (10.1038/mt.2015.67_bib19) 2012; 90 Papadaki (10.1038/mt.2015.67_bib13) 2002; 99 Forbes (10.1038/mt.2015.67_bib5) 2014; 12 Cadwell (10.1038/mt.2015.67_bib46) 2008; 456 Lassen (10.1038/mt.2015.67_bib48) 2014; 111 Fujita (10.1038/mt.2015.67_bib49) 2009; 284 Ren (10.1038/mt.2015.67_bib40) 2011; 13 Copland (10.1038/mt.2015.67_bib27) 2013; 34 Romieu-Mourez (10.1038/mt.2015.67_bib39) 2012; 4 Chinnadurai (10.1038/mt.2015.67_bib28) 2014; 192 Hampe (10.1038/mt.2015.67_bib21) 2007; 39 Gianchecchi (10.1038/mt.2015.67_bib24) 2014; 13 Moll (10.1038/mt.2015.67_bib9) 2014; 32 Chinnadurai (10.1038/mt.2015.67_bib44) 2013; 2013 Galipeau (10.1038/mt.2015.67_bib12) 2013; 15 Nys (10.1038/mt.2015.67_bib25) 2013; 10 Schroepf (10.1038/mt.2015.67_bib43) 2010; 16 Saitoh (10.1038/mt.2015.67_bib45) 2008; 456 Rafei (10.1038/mt.2015.67_bib41) 2008; 112 François (10.1038/mt.2015.67_bib10) 2012; 227 Tardito (10.1038/mt.2015.67_bib20) 2013; 74 Powell (10.1038/mt.2015.67_bib32) 2011; 73 Armaka (10.1038/mt.2015.67_bib33) 2008; 205 Bernardo (10.1038/mt.2015.67_bib2) 2013; 13 Rioux (10.1038/mt.2015.67_bib22) 2007; 39 Plantinga (10.1038/mt.2015.67_bib26) 2011; 60 Rameshwar (10.1038/mt.2015.67_bib11) 2009; 17 Ren (10.1038/mt.2015.67_bib31) 2008; 2 Murphy (10.1038/mt.2015.67_bib3) 2013; 45 Bocelli-Tyndall (10.1038/mt.2015.67_bib17) 2007; 46 Duijvestein (10.1038/mt.2015.67_bib4) 2010; 59 Chinnadurai (10.1038/mt.2015.67_bib50) 2014; 3 Krampera (10.1038/mt.2015.67_bib30) 2013; 15 Lapaquette (10.1038/mt.2015.67_bib23) 2012; 90 Romieu-Mourez (10.1038/mt.2015.67_bib36) 2007; 179 Eliopoulos (10.1038/mt.2015.67_bib8) 2005; 106 Cox (10.1038/mt.2015.67_bib42) 2008; 283 Le Blanc (10.1038/mt.2015.67_bib1) 2012; 12 Nath (10.1038/mt.2015.67_bib29) 2012; 3 Zenewicz (10.1038/mt.2015.67_bib38) 2009; 15 Tang (10.1038/mt.2015.67_bib15) 2012; 2012 Ma (10.1038/mt.2015.67_bib14) 2013; 122 Murthy (10.1038/mt.2015.67_bib47) 2014; 506 Voswinkel (10.1038/mt.2015.67_bib7) 2013; 45 Horwitz (10.1038/mt.2015.67_bib35) 2005; 7 François (10.1038/mt.2015.67_bib51) 2012; 14 18250193 - J Exp Med. 2008 Feb 18;205(2):331-7 16236628 - Cytotherapy. 2005;7(5):393-5 21250865 - Cytotherapy. 2011 Jul;13(6):661-74 20921206 - Gut. 2010 Dec;59(12):1662-9 22243964 - Am J Hum Genet. 2012 Jan 13;90(1):7-24 16923606 - Cytotherapy. 2006;8(4):315-7 16920750 - Rheumatology (Oxford). 2007 Mar;46(3):403-8 22378308 - J Cell Physiol. 2012 Nov;227(11):3535-8 16118325 - Blood. 2005 Dec 15;106(13):4057-65 17526552 - Ann Rheum Dis. 2008 Apr;67(4):443-9 18849965 - Nature. 2008 Nov 13;456(7219):264-8 24160439 - Curr Drug Targets. 2013 Nov;14(12):1453-9 21406388 - Gut. 2011 Sep;60(9):1229-35 24350294 - Biomed Res Int. 2013;2013:929842 18812467 - Blood. 2008 Dec 15;112(13):4991-8 23891515 - Biomaterials. 2013 Oct;34(32):7840-50 19783656 - J Biol Chem. 2009 Nov 20;284(47):32602-9 19180113 - Mol Ther. 2009 Feb;17(2):216-8 24805247 - Stem Cells. 2014 Sep;32(9):2430-42 24403533 - J Immunol. 2014 Feb 15;192(4):1491-501 11861275 - Blood. 2002 Mar 1;99(5):1610-9 17200669 - Nat Genet. 2007 Feb;39(2):207-11 24232253 - Exp Mol Med. 2013;45:e54 18411283 - J Biol Chem. 2008 Jul 11;283(28):19389-99 19362058 - Trends Mol Med. 2009 May;15(5):199-207 21054163 - Annu Rev Physiol. 2011;73:213-37 22029655 - Cytotherapy. 2012 Feb;14(2):147-52 23591407 - Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):395-401 17641021 - J Immunol. 2007 Aug 1;179(3):1549-58 25068122 - Stem Cell Reports. 2014 Jul 8;3(1):60-72 24553140 - Nature. 2014 Feb 27;506(7489):456-62 24094322 - Cell Stem Cell. 2013 Oct 3;13(4):392-402 23872668 - Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71 22797958 - J Mol Med (Berl). 2012 Sep;90(9):987-96 23926306 - Blood. 2013 Sep 19;122(12):2074-82 23200754 - Hum Immunol. 2013 Feb;74(2):166-9 23296948 - Clin Rev Allergy Immunol. 2013 Oct;45(2):180-92 22966240 - Clin Dev Immunol. 2012;2012:826182 18849966 - Nature. 2008 Nov 13;456(7219):259-63 19903096 - Cytotherapy. 2009;11(7):825-36 22201917 - Front Biosci (Elite Ed). 2012;4:824-37 18371435 - Cell Stem Cell. 2008 Feb 7;2(2):141-50 24821797 - Proc Natl Acad Sci U S A. 2014 May 27;111(21):7741-6 23602578 - Cytotherapy. 2013 Sep;15(9):1054-61 23162571 - Front Genet. 2012 Nov 09;3:243 17435756 - Nat Genet. 2007 May;39(5):596-604 24184881 - Autoimmun Rev. 2014 Mar;13(3):231-41 21934657 - Mol Ther. 2012 Jan;20(1):187-95 20848514 - Inflamm Bowel Dis. 2010 Nov;16(11):1882-90 23260081 - Cytotherapy. 2013 Jan;15(1):2-8 22531326 - Nat Rev Immunol. 2012 May;12(5):383-96 |
References_xml | – volume: 46 start-page: 403 year: 2007 end-page: 408 ident: bib17 article-title: Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes publication-title: Rheumatology (Oxford) – volume: 74 start-page: 166 year: 2013 end-page: 169 ident: bib20 article-title: Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis publication-title: Hum Immunol – volume: 456 start-page: 259 year: 2008 end-page: 263 ident: bib46 article-title: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells publication-title: Nature – volume: 106 start-page: 4057 year: 2005 end-page: 4065 ident: bib8 article-title: Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice publication-title: Blood – volume: 73 start-page: 213 year: 2011 end-page: 237 ident: bib32 article-title: Mesenchymal cells of the intestinal lamina propria publication-title: Annu Rev Physiol – volume: 34 start-page: 7840 year: 2013 end-page: 7850 ident: bib27 article-title: The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy publication-title: Biomaterials – volume: 179 start-page: 1549 year: 2007 end-page: 1558 ident: bib36 article-title: Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density publication-title: J Immunol – volume: 12 start-page: 64 year: 2014 end-page: 71 ident: bib5 article-title: A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy publication-title: Clin Gastroenterol Hepatol – volume: 60 start-page: 1229 year: 2011 end-page: 1235 ident: bib26 article-title: Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 publication-title: Gut – volume: 15 start-page: 199 year: 2009 end-page: 207 ident: bib38 article-title: CD4 T-cell differentiation and inflammatory bowel disease publication-title: Trends Mol Med – volume: 14 start-page: 1453 year: 2013 end-page: 1459 ident: bib6 article-title: Cell therapies for IBD: what works? publication-title: Curr Drug Targets – volume: 17 start-page: 216 year: 2009 end-page: 218 ident: bib11 article-title: Casting doubt on the safety of “off-the-shelf” mesenchymal stem cells for cell therapy publication-title: Mol Ther – volume: 2012 start-page: 826182 year: 2012 ident: bib15 article-title: Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus publication-title: Clin Dev Immunol – volume: 13 start-page: 392 year: 2013 end-page: 402 ident: bib2 article-title: Mesenchymal stromal cells: sensors and switchers of inflammation publication-title: Cell Stem Cell – volume: 7 start-page: 393 year: 2005 end-page: 395 ident: bib35 article-title: Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement publication-title: Cytotherapy – volume: 99 start-page: 1610 year: 2002 end-page: 1619 ident: bib13 article-title: Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect publication-title: Blood – volume: 45 start-page: e54 year: 2013 ident: bib3 article-title: Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine publication-title: Exp Mol Med – volume: 13 start-page: 231 year: 2014 end-page: 241 ident: bib24 article-title: Recent insights on the putative role of autophagy in autoimmune diseases publication-title: Autoimmun Rev – volume: 192 start-page: 1491 year: 2014 end-page: 1501 ident: bib28 article-title: IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells publication-title: J Immunol – volume: 90 start-page: 7 year: 2012 end-page: 24 ident: bib19 article-title: Five years of GWAS discovery publication-title: Am J Hum Genet – volume: 506 start-page: 456 year: 2014 end-page: 462 ident: bib47 article-title: A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3 publication-title: Nature – volume: 111 start-page: 7741 year: 2014 end-page: 7746 ident: bib48 article-title: Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense publication-title: Proc Natl Acad Sci U S A – volume: 122 start-page: 2074 year: 2013 end-page: 2082 ident: bib14 article-title: Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia publication-title: Blood – volume: 15 start-page: 1054 year: 2013 end-page: 1061 ident: bib30 article-title: Immunological characterization of multipotent mesenchymal stromal cells–The International Society for Cellular Therapy (ISCT) working proposal publication-title: Cytotherapy – volume: 2 start-page: 141 year: 2008 end-page: 150 ident: bib31 article-title: Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide publication-title: Cell Stem Cell – volume: 11 start-page: 825 year: 2009 end-page: 836 ident: bib18 article-title: Phenotypical/functional characterization of publication-title: Cytotherapy – volume: 3 start-page: 60 year: 2014 end-page: 72 ident: bib50 article-title: Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo publication-title: Stem Cell Reports – volume: 16 start-page: 1882 year: 2010 end-page: 1890 ident: bib43 article-title: Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease publication-title: Inflamm Bowel Dis – volume: 8 start-page: 315 year: 2006 end-page: 317 ident: bib34 article-title: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement publication-title: Cytotherapy – volume: 3 start-page: 243 year: 2012 ident: bib29 article-title: Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in fijians publication-title: Front Genet – volume: 15 start-page: 2 year: 2013 end-page: 8 ident: bib12 article-title: The mesenchymal stromal cells dilemma–does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? publication-title: Cytotherapy – volume: 39 start-page: 596 year: 2007 end-page: 604 ident: bib22 article-title: Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis publication-title: Nat Genet – volume: 227 start-page: 3535 year: 2012 end-page: 3538 ident: bib10 article-title: New insights on translational development of mesenchymal stromal cells for suppressor therapy publication-title: J Cell Physiol – volume: 205 start-page: 331 year: 2008 end-page: 337 ident: bib33 article-title: Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases publication-title: J Exp Med – volume: 67 start-page: 443 year: 2008 end-page: 449 ident: bib16 article-title: Phenotypical and functional characteristics of publication-title: Ann Rheum Dis – volume: 4 start-page: 824 year: 2012 end-page: 837 ident: bib39 article-title: The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies publication-title: Front Biosci (Elite Ed) – volume: 39 start-page: 207 year: 2007 end-page: 211 ident: bib21 article-title: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 publication-title: Nat Genet – volume: 284 start-page: 32602 year: 2009 end-page: 32609 ident: bib49 article-title: Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: analysis of the organization of the Atg16L1 complex in fibroblasts publication-title: J Biol Chem – volume: 45 start-page: 180 year: 2013 end-page: 192 ident: bib7 article-title: Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review publication-title: Clin Rev Allergy Immunol – volume: 456 start-page: 264 year: 2008 end-page: 268 ident: bib45 article-title: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production publication-title: Nature – volume: 112 start-page: 4991 year: 2008 end-page: 4998 ident: bib41 article-title: Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction publication-title: Blood – volume: 13 start-page: 661 year: 2011 end-page: 674 ident: bib40 article-title: Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency publication-title: Cytotherapy – volume: 90 start-page: 987 year: 2012 end-page: 996 ident: bib23 article-title: Etiology of Crohn's disease: many roads lead to autophagy publication-title: J Mol Med (Berl) – volume: 283 start-page: 19389 year: 2008 end-page: 19399 ident: bib42 article-title: Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding publication-title: J Biol Chem – volume: 20 start-page: 187 year: 2012 end-page: 195 ident: bib37 article-title: Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation publication-title: Mol Ther – volume: 10 start-page: 395 year: 2013 end-page: 401 ident: bib25 article-title: Autophagy: a new target or an old strategy for the treatment of Crohn's disease? publication-title: Nat Rev Gastroenterol Hepatol – volume: 2013 start-page: 929842 year: 2013 ident: bib44 article-title: From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases publication-title: Biomed Res Int – volume: 12 start-page: 383 year: 2012 end-page: 396 ident: bib1 article-title: Multipotent mesenchymal stromal cells and the innate immune system publication-title: Nat Rev Immunol – volume: 59 start-page: 1662 year: 2010 end-page: 1669 ident: bib4 article-title: Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study publication-title: Gut – volume: 32 start-page: 2430 year: 2014 end-page: 2442 ident: bib9 article-title: Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? publication-title: Stem Cells – volume: 14 start-page: 147 year: 2012 end-page: 152 ident: bib51 article-title: Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing publication-title: Cytotherapy – volume: 3 start-page: 243 year: 2012 ident: 10.1038/mt.2015.67_bib29 article-title: Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in fijians publication-title: Front Genet doi: 10.3389/fgene.2012.00243 – volume: 11 start-page: 825 year: 2009 ident: 10.1038/mt.2015.67_bib18 article-title: Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease publication-title: Cytotherapy doi: 10.3109/14653240903121260 – volume: 4 start-page: 824 year: 2012 ident: 10.1038/mt.2015.67_bib39 article-title: The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies publication-title: Front Biosci (Elite Ed) – volume: 122 start-page: 2074 year: 2013 ident: 10.1038/mt.2015.67_bib14 article-title: Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia publication-title: Blood doi: 10.1182/blood-2013-03-491555 – volume: 12 start-page: 64 year: 2014 ident: 10.1038/mt.2015.67_bib5 article-title: A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2013.06.021 – volume: 227 start-page: 3535 year: 2012 ident: 10.1038/mt.2015.67_bib10 article-title: New insights on translational development of mesenchymal stromal cells for suppressor therapy publication-title: J Cell Physiol doi: 10.1002/jcp.24081 – volume: 111 start-page: 7741 year: 2014 ident: 10.1038/mt.2015.67_bib48 article-title: Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1407001111 – volume: 284 start-page: 32602 year: 2009 ident: 10.1038/mt.2015.67_bib49 article-title: Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: analysis of the organization of the Atg16L1 complex in fibroblasts publication-title: J Biol Chem doi: 10.1074/jbc.M109.037671 – volume: 10 start-page: 395 year: 2013 ident: 10.1038/mt.2015.67_bib25 article-title: Autophagy: a new target or an old strategy for the treatment of Crohn's disease? publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2013.66 – volume: 90 start-page: 987 year: 2012 ident: 10.1038/mt.2015.67_bib23 article-title: Etiology of Crohn's disease: many roads lead to autophagy publication-title: J Mol Med (Berl) doi: 10.1007/s00109-012-0934-8 – volume: 13 start-page: 231 year: 2014 ident: 10.1038/mt.2015.67_bib24 article-title: Recent insights on the putative role of autophagy in autoimmune diseases publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2013.10.007 – volume: 15 start-page: 199 year: 2009 ident: 10.1038/mt.2015.67_bib38 article-title: CD4 T-cell differentiation and inflammatory bowel disease publication-title: Trends Mol Med doi: 10.1016/j.molmed.2009.03.002 – volume: 15 start-page: 2 year: 2013 ident: 10.1038/mt.2015.67_bib12 article-title: The mesenchymal stromal cells dilemma–does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? publication-title: Cytotherapy doi: 10.1016/j.jcyt.2012.10.002 – volume: 45 start-page: e54 year: 2013 ident: 10.1038/mt.2015.67_bib3 article-title: Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine publication-title: Exp Mol Med doi: 10.1038/emm.2013.94 – volume: 456 start-page: 264 year: 2008 ident: 10.1038/mt.2015.67_bib45 article-title: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production publication-title: Nature doi: 10.1038/nature07383 – volume: 20 start-page: 187 year: 2012 ident: 10.1038/mt.2015.67_bib37 article-title: Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation publication-title: Mol Ther doi: 10.1038/mt.2011.189 – volume: 32 start-page: 2430 year: 2014 ident: 10.1038/mt.2015.67_bib9 article-title: Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? publication-title: Stem Cells doi: 10.1002/stem.1729 – volume: 283 start-page: 19389 year: 2008 ident: 10.1038/mt.2015.67_bib42 article-title: Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding publication-title: J Biol Chem doi: 10.1074/jbc.M800266200 – volume: 45 start-page: 180 year: 2013 ident: 10.1038/mt.2015.67_bib7 article-title: Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-012-8347-6 – volume: 13 start-page: 661 year: 2011 ident: 10.1038/mt.2015.67_bib40 article-title: Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency publication-title: Cytotherapy doi: 10.3109/14653249.2010.548379 – volume: 12 start-page: 383 year: 2012 ident: 10.1038/mt.2015.67_bib1 article-title: Multipotent mesenchymal stromal cells and the innate immune system publication-title: Nat Rev Immunol doi: 10.1038/nri3209 – volume: 112 start-page: 4991 year: 2008 ident: 10.1038/mt.2015.67_bib41 article-title: Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction publication-title: Blood doi: 10.1182/blood-2008-07-166892 – volume: 8 start-page: 315 year: 2006 ident: 10.1038/mt.2015.67_bib34 article-title: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement publication-title: Cytotherapy doi: 10.1080/14653240600855905 – volume: 99 start-page: 1610 year: 2002 ident: 10.1038/mt.2015.67_bib13 article-title: Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect publication-title: Blood doi: 10.1182/blood.V99.5.1610 – volume: 15 start-page: 1054 year: 2013 ident: 10.1038/mt.2015.67_bib30 article-title: Immunological characterization of multipotent mesenchymal stromal cells–The International Society for Cellular Therapy (ISCT) working proposal publication-title: Cytotherapy doi: 10.1016/j.jcyt.2013.02.010 – volume: 2 start-page: 141 year: 2008 ident: 10.1038/mt.2015.67_bib31 article-title: Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide publication-title: Cell Stem Cell doi: 10.1016/j.stem.2007.11.014 – volume: 2013 start-page: 929842 year: 2013 ident: 10.1038/mt.2015.67_bib44 article-title: From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases publication-title: Biomed Res Int doi: 10.1155/2013/929842 – volume: 14 start-page: 1453 year: 2013 ident: 10.1038/mt.2015.67_bib6 article-title: Cell therapies for IBD: what works? publication-title: Curr Drug Targets doi: 10.2174/13894501113146660234 – volume: 73 start-page: 213 year: 2011 ident: 10.1038/mt.2015.67_bib32 article-title: Mesenchymal cells of the intestinal lamina propria publication-title: Annu Rev Physiol doi: 10.1146/annurev.physiol.70.113006.100646 – volume: 506 start-page: 456 year: 2014 ident: 10.1038/mt.2015.67_bib47 article-title: A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3 publication-title: Nature doi: 10.1038/nature13044 – volume: 90 start-page: 7 year: 2012 ident: 10.1038/mt.2015.67_bib19 article-title: Five years of GWAS discovery publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2011.11.029 – volume: 13 start-page: 392 year: 2013 ident: 10.1038/mt.2015.67_bib2 article-title: Mesenchymal stromal cells: sensors and switchers of inflammation publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.09.006 – volume: 67 start-page: 443 year: 2008 ident: 10.1038/mt.2015.67_bib16 article-title: Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis publication-title: Ann Rheum Dis doi: 10.1136/ard.2007.071233 – volume: 179 start-page: 1549 year: 2007 ident: 10.1038/mt.2015.67_bib36 article-title: Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density publication-title: J Immunol doi: 10.4049/jimmunol.179.3.1549 – volume: 39 start-page: 596 year: 2007 ident: 10.1038/mt.2015.67_bib22 article-title: Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis publication-title: Nat Genet doi: 10.1038/ng2032 – volume: 59 start-page: 1662 year: 2010 ident: 10.1038/mt.2015.67_bib4 article-title: Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study publication-title: Gut doi: 10.1136/gut.2010.215152 – volume: 60 start-page: 1229 year: 2011 ident: 10.1038/mt.2015.67_bib26 article-title: Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 publication-title: Gut doi: 10.1136/gut.2010.228908 – volume: 192 start-page: 1491 year: 2014 ident: 10.1038/mt.2015.67_bib28 article-title: IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells publication-title: J Immunol doi: 10.4049/jimmunol.1301828 – volume: 3 start-page: 60 year: 2014 ident: 10.1038/mt.2015.67_bib50 article-title: Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo publication-title: Stem Cell Reports doi: 10.1016/j.stemcr.2014.05.003 – volume: 2012 start-page: 826182 year: 2012 ident: 10.1038/mt.2015.67_bib15 article-title: Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus publication-title: Clin Dev Immunol doi: 10.1155/2012/826182 – volume: 46 start-page: 403 year: 2007 ident: 10.1038/mt.2015.67_bib17 article-title: Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kel267 – volume: 456 start-page: 259 year: 2008 ident: 10.1038/mt.2015.67_bib46 article-title: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells publication-title: Nature doi: 10.1038/nature07416 – volume: 17 start-page: 216 year: 2009 ident: 10.1038/mt.2015.67_bib11 article-title: Casting doubt on the safety of “off-the-shelf” mesenchymal stem cells for cell therapy publication-title: Mol Ther doi: 10.1038/mt.2008.296 – volume: 205 start-page: 331 year: 2008 ident: 10.1038/mt.2015.67_bib33 article-title: Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases publication-title: J Exp Med doi: 10.1084/jem.20070906 – volume: 14 start-page: 147 year: 2012 ident: 10.1038/mt.2015.67_bib51 article-title: Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing publication-title: Cytotherapy doi: 10.3109/14653249.2011.623691 – volume: 7 start-page: 393 year: 2005 ident: 10.1038/mt.2015.67_bib35 article-title: Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement publication-title: Cytotherapy doi: 10.1080/14653240500319234 – volume: 74 start-page: 166 year: 2013 ident: 10.1038/mt.2015.67_bib20 article-title: Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis publication-title: Hum Immunol doi: 10.1016/j.humimm.2012.11.008 – volume: 34 start-page: 7840 year: 2013 ident: 10.1038/mt.2015.67_bib27 article-title: The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.06.050 – volume: 16 start-page: 1882 year: 2010 ident: 10.1038/mt.2015.67_bib43 article-title: Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.21312 – volume: 106 start-page: 4057 year: 2005 ident: 10.1038/mt.2015.67_bib8 article-title: Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice publication-title: Blood doi: 10.1182/blood-2005-03-1004 – volume: 39 start-page: 207 year: 2007 ident: 10.1038/mt.2015.67_bib21 article-title: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 publication-title: Nat Genet doi: 10.1038/ng1954 – reference: 18371435 - Cell Stem Cell. 2008 Feb 7;2(2):141-50 – reference: 24160439 - Curr Drug Targets. 2013 Nov;14(12):1453-9 – reference: 23872668 - Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71 – reference: 22531326 - Nat Rev Immunol. 2012 May;12(5):383-96 – reference: 17435756 - Nat Genet. 2007 May;39(5):596-604 – reference: 19783656 - J Biol Chem. 2009 Nov 20;284(47):32602-9 – reference: 18849966 - Nature. 2008 Nov 13;456(7219):259-63 – reference: 23260081 - Cytotherapy. 2013 Jan;15(1):2-8 – reference: 22378308 - J Cell Physiol. 2012 Nov;227(11):3535-8 – reference: 24553140 - Nature. 2014 Feb 27;506(7489):456-62 – reference: 25068122 - Stem Cell Reports. 2014 Jul 8;3(1):60-72 – reference: 24821797 - Proc Natl Acad Sci U S A. 2014 May 27;111(21):7741-6 – reference: 16920750 - Rheumatology (Oxford). 2007 Mar;46(3):403-8 – reference: 21054163 - Annu Rev Physiol. 2011;73:213-37 – reference: 22797958 - J Mol Med (Berl). 2012 Sep;90(9):987-96 – reference: 22966240 - Clin Dev Immunol. 2012;2012:826182 – reference: 16923606 - Cytotherapy. 2006;8(4):315-7 – reference: 20848514 - Inflamm Bowel Dis. 2010 Nov;16(11):1882-90 – reference: 24350294 - Biomed Res Int. 2013;2013:929842 – reference: 11861275 - Blood. 2002 Mar 1;99(5):1610-9 – reference: 18849965 - Nature. 2008 Nov 13;456(7219):264-8 – reference: 22243964 - Am J Hum Genet. 2012 Jan 13;90(1):7-24 – reference: 18411283 - J Biol Chem. 2008 Jul 11;283(28):19389-99 – reference: 22201917 - Front Biosci (Elite Ed). 2012;4:824-37 – reference: 17200669 - Nat Genet. 2007 Feb;39(2):207-11 – reference: 24232253 - Exp Mol Med. 2013;45:e54 – reference: 23591407 - Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):395-401 – reference: 24094322 - Cell Stem Cell. 2013 Oct 3;13(4):392-402 – reference: 24184881 - Autoimmun Rev. 2014 Mar;13(3):231-41 – reference: 19362058 - Trends Mol Med. 2009 May;15(5):199-207 – reference: 24403533 - J Immunol. 2014 Feb 15;192(4):1491-501 – reference: 22029655 - Cytotherapy. 2012 Feb;14(2):147-52 – reference: 21250865 - Cytotherapy. 2011 Jul;13(6):661-74 – reference: 18812467 - Blood. 2008 Dec 15;112(13):4991-8 – reference: 20921206 - Gut. 2010 Dec;59(12):1662-9 – reference: 23602578 - Cytotherapy. 2013 Sep;15(9):1054-61 – reference: 24805247 - Stem Cells. 2014 Sep;32(9):2430-42 – reference: 23891515 - Biomaterials. 2013 Oct;34(32):7840-50 – reference: 21406388 - Gut. 2011 Sep;60(9):1229-35 – reference: 17526552 - Ann Rheum Dis. 2008 Apr;67(4):443-9 – reference: 18250193 - J Exp Med. 2008 Feb 18;205(2):331-7 – reference: 23296948 - Clin Rev Allergy Immunol. 2013 Oct;45(2):180-92 – reference: 19180113 - Mol Ther. 2009 Feb;17(2):216-8 – reference: 16236628 - Cytotherapy. 2005;7(5):393-5 – reference: 19903096 - Cytotherapy. 2009;11(7):825-36 – reference: 23200754 - Hum Immunol. 2013 Feb;74(2):166-9 – reference: 17641021 - J Immunol. 2007 Aug 1;179(3):1549-58 – reference: 23926306 - Blood. 2013 Sep 19;122(12):2074-82 – reference: 23162571 - Front Genet. 2012 Nov 09;3:243 – reference: 21934657 - Mol Ther. 2012 Jan;20(1):187-95 – reference: 16118325 - Blood. 2005 Dec 15;106(13):4057-65 |
SSID | ssj0011596 |
Score | 2.3814728 |
Snippet | Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials.... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1248 |
SubjectTerms | Autophagy Autophagy - immunology Bone marrow Bone Marrow Cells Cell Proliferation - genetics Clinical trials Coculture Techniques Crohn Disease - genetics Crohn Disease - immunology Crohn Disease - pathology Crohn's disease Genotype & phenotype Hematology Humans Immunosuppression Indoleamine-Pyrrole 2,3,-Dioxygenase - biosynthesis Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics Indoleamine-Pyrrole 2,3,-Dioxygenase - immunology Interferon-gamma - biosynthesis Interferon-gamma - genetics Interferon-gamma - immunology Lymphocyte Activation - immunology Mesenchymal Stromal Cells - immunology Mesenchymal Stromal Cells - pathology Oncology Original Polymorphism T-Lymphocytes - immunology |
Title | Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy |
URI | https://dx.doi.org/10.1038/mt.2015.67 https://www.ncbi.nlm.nih.gov/pubmed/25899824 https://www.proquest.com/docview/1791335748 https://www.proquest.com/docview/1692753925 https://www.proquest.com/docview/1776654109 https://pubmed.ncbi.nlm.nih.gov/PMC4817795 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELZgE4gvCMZbYExGICGkeWsSO7Y_odGtWkGdJhhSv0WO49BJbTLaFNF_wU_mLnEDg2qKlCjxJUp059zZd34eQt7YUGdG9QzLokQx8NecaS4KZlRswNvrUDuc0B-dJadf-cexGPsJt4Uvq1z_E5sfdV5ZnCM_RBjNOBaSq_dX3xmyRmF21VNo3CbbCF2GVi3H3YALgp2GnwspfhjGNmt40lgdzrCOMhQHDb_8Rof0f8D5b93kX45o8IDc9xEkPWpV_pDccuUOudNySq52yN2Rz5Y_Ir9GuLTITlYzkP9Szys89t10uqDHYHg_XE4HcJH259WkfLug5y3GKrYiDTAdlgj3ZGbwMBrtxyy_rH6uwODA8bFmxQlEq3SIC0wcRXbQtqS23McbPbduTauCHi0RvcB8Wz0mF4OTi_4p8wwMzMKwWbKwUCbhmYW90CIDTcrc8jxJCsxmmiLsOVnkuTYiMbAp6UykDBc6tzIMbfyEbJVV6Z4RmnNkSXJhAY28KCKjklgKkYVwTxRbF5B3ay2k1qOTI0nGNG2y5LFKZ3WKGksTGZDXnexVi8mxUYqtlZn6aKKNElJwFhvld9caT30_XqR_rC4gr7pm6IGYVjGlq5Ygk-gIBn06EjfISIk0z2FPB-Rpa0Tdq0cCx7wRD4i8Zl6dACKAX28pLycNEjhX8GAtnt_86i_IPfzGtsh4l2zV86V7CaFUne01_WWPbH84OTv_DGfHw0-_AYxaImk |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELbGEC9fEIy3wgAjQAhpZo1jx_YHhKaOqWXrhEQn9ZvlJA6d1CajL0D_BX-E_8hdXgqDat-mSIkUXyxHd_bd-c73EPIyCUzsdNuxmEeagb4WzAiZMadDB9reBMbjhn7_OOqeiI9DOdwgv5qzMJhW2ayJ5UKdFgnuke9iGc0wlEro92dfGaJGYXS1gdCoxOLQL7-DyzZ719sH_r7i_ODDoNNlNaoAS8AVVCzItItEnMBdGhnD6FSaiDSKMozQuSxoe5WlqXEycnBp5R3XTkiTJioIkhC6vUKugt5to6-nhiv_DmyrEg4MEYUYmlJNNdRQ704wbTOQb0s4-7X673_79t80zb_03sFtcqs2WOleJWF3yIbPt8i1CsJyuUWu9-vg_F3ys48nmZLRcgL0n-fTAp8dPx7P6D7I-Tef0gN4STvTYpS_ntFPVUlXbEXUYdrLsbqUm0BnlO-ELD0tfixBvkHPsvKACxjHtIfnWTxFMNIqgzffwQ9rKN85LTK6t8BiCe7L8h4ZXAZr7pPNvMj9Q0JTgaBMPsigUWQZdzoKlZRxAN_wMPEt8qbhgk3qYuiIyTG2ZVA-1HYyt8gxG6kWebGiPatKgKylYg0zbW28VEaJBd20ln674bitl42Z_SPkLfJ81QwTHqM4LvfFAmgiw8HHNFxeQKMUokoHbdMiDyohWg2dS3SxuWgRdU68VgRYcPx8S346KguPCw0dG_no4qE_Ize6g_6RPeodHz4mN_F_q_zmbbI5ny78E7Di5vHTcu5QYi95rv4GZ8VcIQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+Stromal+Cells+Derived+From+Crohn%27s+Patients+Deploy+Indoleamine+2%2C3-dioxygenase-mediated+Immune+Suppression%2C+Independent+of+Autophagy&rft.jtitle=Molecular+therapy&rft.au=Chinnadurai%2C+Raghavan&rft.au=Copland%2C+Ian+B&rft.au=Ng%2C+Spencer&rft.au=Garcia%2C+Marco&rft.date=2015-07-01&rft.pub=Nature+Publishing+Group&rft.issn=1525-0016&rft.eissn=1525-0024&rft.volume=23&rft.issue=7&rft.spage=1248&rft.epage=1261&rft_id=info:doi/10.1038%2Fmt.2015.67&rft_id=info%3Apmid%2F25899824&rft.externalDocID=PMC4817795 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-0016&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-0016&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-0016&client=summon |